Back to Screener

Healthcare

Ipsen S.A.(IPSEF)

Live Price

Offline

$113.13

+0.00% today

1Y Change

+0.00%

Window

Jun 30, 2025 โ†’ Jun 18, 2026

Market Cap
$13.81B
Revenue Growth
+2.8%
EPS Growth
+23.1%
Dividend Yield
0.8%

Coverage: 250 bars ยท Jun 30, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Ipsen S.A. (IPSEF) is a Healthcare stock with a market cap of $13.81B and listed on OTC. The stock last traded around $113.13 and up 0.0% across the available one-year price window (Jun 30, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +2.8%, EPS growth of +23.1%, a dividend yield of 0.8%. What stands out right now is revenue +2.8%, EPS +23.1%, free cash flow +676.5% with operating margin 30.7% and ROIC 15.4%. The dividend is present but secondary, with a yield around 0.8%. Valuation already assumes a fairly strong business story at P/E 31.0 and price/sales 3.8. Stock Foundry combines IPSEF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

IPSEF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

Mixed setup vs SPY

IPSEF is 20.86 pts behind over the shared 1Y window.

IPSEF had 9.13 pts shallower max drawdown than SPY.

IPSEF beat SPY in 0 of 2 calendar years shown and trailed in 2.

IPSEF

+0.00%

Normalized return

SPY

+20.86%

S&P 500

Excess Return

-20.86 pts

Relative to SPY

IPSEF Max Drawdown

0.00%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

IPSEFSPY

Calendar-Year Returns

Uses the longest available daily history for IPSEF and SPY.

YearIPSEFSPYExcessLeader
20260.00%+6.71%-6.71 ptsSPY
20250.00%+11.19%-11.19 ptsSPY

Unable to load analyst forecasts.

Timed out loading forecasts for IPSEF

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.